Claims for Patent: 4,061,779
✉ Email this page to a colleague
Summary for Patent: 4,061,779
Title: | Naphthalene derivatives having anti-inflammatory activity |
Abstract: | 4-(6'-Methoxy-2'-naphthyl) butan-2-one is described as having anti-inflammatory activity and an improved therapeutic ratio. |
Inventor(s): | Lake; Anthony William (Saffron Waldon, EN), Rose; Carl John (London, EN) |
Assignee: | Beecham Group Limited (UK) |
Application Number: | 05/748,676 |
Patent Claims: |
1. A pharmaceutical composition useful for treating inflammation in humans which comprises an anti-inflammatory effective amount of the compound of the formula: ##STR26## in
combination with a pharmaceutically acceptable carrier.
2. A pharmaceutical composition according to claim 1 in oral administration form. 3. A pharmaceutical composition according to claim 1 in unit dose form for oral administration to humans which comprises from 20 mg to 1000 mg of a compound of the formula: ##STR27## 4. A pharmaceutical composition according to claim 3 in tablet or capsule form which comprises from 100 mg to 600 mg of a compound of the formula: ##STR28## 5. A pharmaceutical composition useful for the treatment of rheumatic and arthritic conditions in humans which comprises a therapeutically effective amount of a compound of the formula ##STR29## in combination with a pharmaceutically acceptable carrier. 6. A pharmaceutical composition according to claim 5 in oral administration form. 7. A method of reducing inflammation in humans which comprises administering to a human in need thereof an amount of a composition of claim 1 sufficient to produce an anti-inflammatory effect without an undesired oestrogenic effect. 8. A method according to claim 7 wherein the composition is administered orally. 9. A method according to claim 8 wherein the composition is in the form of a unit dose for oral administration wherein each unit dose contains from 20 mg to 1000 mg of said compound. 10. A method according to claim 8 wherein the composition is in the form of a unit dose for oral administration wherein each unit dose contains from 100 mg to 600 mg of the compound. 11. A method of treating rheumatic and arthritic conditions in humans which comprises administering to a human in need thereof an amount of a composition of claim 5 sufficient to provide relief from the rheumatic or arthritic condition being treated. 12. A method according to claim 11 wherein the composition is administered orally. 13. Solid 4-(6'-methoxy-2'-naphthyl)butan-2-one hving a melting poit of not less than 78.5.degree. C. |